Endometriosis Is Undervalued: A Call to Action
- PMID: 35620300
- PMCID: PMC9127440
- DOI: 10.3389/fgwh.2022.902371
Endometriosis Is Undervalued: A Call to Action
Abstract
Endometriosis is an inflammatory chronic pain condition caused by uterine tissue growing outside of the uterus that afflicts at least 11% of women (and people assigned female at birth) worldwide. This condition results in a substantial burden to these women, and society at large. Although endometriosis was first identified over 160 years ago, substantial knowledge gaps remain, including confirmation of the disease's etiology. Research funding for endometriosis is limited, with funding from bodies like the National Institutes of Health (NIH) constituting only 0.038% of the 2022 health budget-for a condition that affects 6.5 million women in the US alone and over 190 million worldwide. A major issue is that diagnosis of endometriosis is frequently delayed because surgery is required to histologically confirm the diagnosis. This delay increases symptom intensity, the risk of central and peripheral sensitization and the costs of the disease for the patient and their nation. Current conservative treatments of presumed endometriosis are pain management and birth control. Both of these methods are flawed and can be entirely ineffective for the reduction of patient suffering or improving ability to work, and neither addresses the severe infertility issues or higher risk of certain cancers. Endometriosis research deserves the funding and attention that befits a disease with its substantial prevalence, effects, and economic costs. This funding could improve patient outcomes by introducing less invasive and more timely methods for diagnosis and treatment, including options such as novel biomarkers, nanomedicine, and microbiome alterations.
Keywords: chronic pain; endometriosis; funding; quality of life; women's health.
Copyright © 2022 Ellis, Munro and Clarke.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Pathophysiology, diagnosis, and management of endometriosis.BMJ. 2022 Nov 14;379:e070750. doi: 10.1136/bmj-2022-070750. BMJ. 2022. PMID: 36375827 Review.
-
Clinical diagnosis of endometriosis: a call to action.Am J Obstet Gynecol. 2019 Apr;220(4):354.e1-354.e12. doi: 10.1016/j.ajog.2018.12.039. Epub 2019 Jan 6. Am J Obstet Gynecol. 2019. PMID: 30625295
-
Assessing research gaps and unmet needs in endometriosis.Am J Obstet Gynecol. 2019 Aug;221(2):86-94. doi: 10.1016/j.ajog.2019.02.033. Epub 2019 Feb 18. Am J Obstet Gynecol. 2019. PMID: 30790565 Review.
-
Long-term follow-up of endometriosis surgery in Ontario: a population-based cohort study.Am J Obstet Gynecol. 2021 Sep;225(3):270.e1-270.e19. doi: 10.1016/j.ajog.2021.04.237. Epub 2021 Apr 21. Am J Obstet Gynecol. 2021. PMID: 33894154
-
Lessons from implementing the Australian National Action Plan for Endometriosis.Reprod Fertil. 2022 Jun 30;3(3):C29-C39. doi: 10.1530/RAF-22-0003. eCollection 2022 Jul 1. Reprod Fertil. 2022. PMID: 35928674 Free PMC article.
Cited by
-
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2322934121. doi: 10.1073/pnas.2322934121. Epub 2024 May 3. Proc Natl Acad Sci U S A. 2024. PMID: 38701119
-
Assessing the Utility of artificial intelligence in endometriosis: Promises and pitfalls.Womens Health (Lond). 2024 Jan-Dec;20:17455057241248121. doi: 10.1177/17455057241248121. Womens Health (Lond). 2024. PMID: 38686828 Free PMC article. Review.
-
Fusobacterium nucleatum: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers.Cells. 2024 Apr 20;13(8):717. doi: 10.3390/cells13080717. Cells. 2024. PMID: 38667331 Free PMC article. Review.
-
The (cost-) effectiveness Of Surgical excision of Colorectal endometriosis compared to ART treatment trAjectory (TOSCA study) - a study protocol.Reprod Fertil. 2024 Apr 1;5(2):e230048. doi: 10.1530/RAF-23-0048. Online ahead of print. Reprod Fertil. 2024. PMID: 38583465 Free PMC article.
-
Impaired bone morphogenetic protein (BMP) signaling pathways disrupt decidualization in endometriosis.Commun Biol. 2024 Feb 24;7(1):227. doi: 10.1038/s42003-024-05898-z. Commun Biol. 2024. PMID: 38402336 Free PMC article.
References
-
- Mehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. (2014) 7:349–57. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233437/pdf/JMedLife-07-349... - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous